Schedule 13G ownership disclosure
PSYENCE BIOMEDICAL LTD
Common Shares, no par value · CUSIP: 74449F209
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Hudson Bay Capital Management LP
Shares: 380,000.00 · Class: 9.98%
- Sander Gerber
Shares: 380,000.00 · Class: 9.98%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002033916-25-000025
- Form type
- SCHEDULE 13G/A
- Filer
- Hudson Bay Capital Management LP
- CIK
- CIK 1393825
- Filed
- Feb 10, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership